Terminal Access

Unlimited access to the most powerful analytical tools in finance.

Bloomberg Fair Value
20M Securities
50Y History
10Y Estimates
8.000+ News Daily
Subscribe for $2
Overview
Profile

SciDev stock

SDV.AX
AU000000SDV5
A2DNJ3

Price

0
Today +/-
-0
Today %
-0 %

SciDev stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the SciDev stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the SciDev stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the SciDev stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze SciDev's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

SciDev Stock Price History

DateSciDev Price
4/8/20250 undefined
4/7/20250.39 undefined
4/4/20250.43 undefined
4/3/20250.43 undefined
4/2/20250.44 undefined
4/1/20250.45 undefined
3/31/20250.45 undefined
3/28/20250.46 undefined
3/27/20250.46 undefined
3/26/20250.47 undefined
3/25/20250.42 undefined
3/24/20250.43 undefined
3/21/20250.43 undefined
3/20/20250.45 undefined
3/19/20250.45 undefined
3/18/20250.43 undefined
3/17/20250.45 undefined
3/14/20250.48 undefined
3/13/20250.45 undefined
3/12/20250.42 undefined
3/11/20250.42 undefined
3/10/20250.44 undefined

SciDev Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into SciDev, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by SciDev from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects SciDev’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of SciDev. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into SciDev’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing SciDev’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on SciDev’s growth potential.

SciDev Revenue, EBIT and net profit per share

DateSciDev RevenueSciDev EBITSciDev Net Income
2027e141.1 M undefined9.9 M undefined6.53 M undefined
2026e128.67 M undefined8.28 M undefined5.38 M undefined
2025e110.19 M undefined4.65 M undefined2.88 M undefined
2024109.09 M undefined4.77 M undefined2.18 M undefined
202389.72 M undefined571,000 undefined-339,000 undefined
202255.6 M undefined-315,000 undefined-616,000 undefined
202142.53 M undefined-718,900 undefined3.45 M undefined
202018.06 M undefined-2.82 M undefined-875,200 undefined
20192.92 M undefined-2.31 M undefined-2.03 M undefined
20182.21 M undefined-1.34 M undefined1 M undefined
20171.93 M undefined-691,000 undefined-682,200 undefined
20161.77 M undefined-346,700 undefined-480,600 undefined
20151.54 M undefined-876,800 undefined-816,100 undefined
20141.28 M undefined-1.16 M undefined-1.18 M undefined
20131.07 M undefined-1.87 M undefined-2.57 M undefined
20122.83 M undefined-4.97 M undefined-3.1 M undefined
20118.82 M undefined2.33 M undefined1.52 M undefined
2010760,000 undefined-4.26 M undefined-1.78 M undefined
20091.45 M undefined-5.45 M undefined-21.53 M undefined
200827.2 M undefined940,000 undefined-2.83 M undefined
20079.56 M undefined-2.14 M undefined-1.17 M undefined
20063.11 M undefined-8.05 M undefined-4.51 M undefined
20052.22 M undefined-3.44 M undefined-3.56 M undefined

SciDev Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
1200001239271082111112218425589109110128141
-100.00-----100.0050.00200.00200.00-96.30---75.00-50.00----100.00-800.00133.3330.9561.8222.470.9216.3610.16
3,300.001,650.00----3,300.001,650.001,100.0011.1137.043,300.00-100.00100.00100.00100.00100.00100.003,300.001,650.001,650.0016.6723.8130.9126.9730.2830.0025.7823.40
00000000011000821111000310172433000
0-5-30-3-3-2-3-4-1-2-21-11-3-2-10001-203002256
---40.00----33.3350.0033.33-75.00100.00950.00-95.24-200.00-400.00-33.33-50.00-----300.00------150.0020.00
0.620.620.620.621.351.632.483.94.96.145.927.289.6520.0126.1532.2632.2632.2632.2641.5953.2975.68127.53154.75177.37189.68189.85000
------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The SciDev Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the SciDev is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (k)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (k)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                     
2.343.530.991.153.750.731.14.556.492.975.221.990.193.124.143.441.750.930.480.940.571.764.487.0114.067.739.43
0.020.020.030.0300000.034.841.190.270.010.880.050.10.190.330.220.330.730.812.176.9610.117.8612.29
000000000.220.330.140.030.020.010.480000.010000.031.160.170.380
0000000003.433.230.020.040.040.030.030.190.260.280.230.240.264.813.797.356.937.53
00.48000.010.020.030.030.020.360.073.750.030.020.020000000.020.150.340.440.630.8
2.364.031.021.183.760.751.134.586.7611.939.856.060.294.074.723.572.131.510.981.511.532.8511.6419.2732.1223.5430.04
0.040.030.110.080.090.11.725.7926.2734.2633.974.23.452.72.040.50.290.220.230.290.260.31.26.387.7712.7311.51
00000001.080.933.24.070.785.593.690.050.210.040.06001.51.51.52.721.730.410.45
0000000.240.240.191.211.1302.762.760.2300000000000.310.16
7000000.010.010.010.010.010.010.010.010.010.011.321.291.271.281.271.2511.40.525.34.764.21
0.420.4900000000000000000000023.6120.5820.8620.83
3.930.130000000000.120.120.160.1600000001.433.653.664.764.8
11.390.650.110.080.090.11.977.1227.438.6839.185.1111.939.322.490.721.651.571.51.573.033.0515.5336.8839.0443.8341.97
13.754.681.131.263.850.853.111.734.1650.6149.0311.1712.2213.397.214.293.783.082.493.084.565.927.1756.1571.1667.3772.01
                                                     
15.0220.9520.9923.7829.7529.7533.8445.2456.6859.4264.4866.7568.9870.4271.6471.6471.6471.6471.6473.6774.1276.989.87101119.24119.49119.49
000000000000000000000000000
-6.82-19.08-23.06-23.04-26.14-29.34-31.38-34.94-25.18-38.66-41.06-61.72-63.5-61.98-65.03-67.6-68.78-69.55-70.05-71.21-70.17-72.2-73.04-69.38-69.92-70.26-67.98
0000000000000000000000570-809.2-486-117-221
00000000013.6413.640000000000000.810-1.09-1.05
8.21.87-2.070.743.610.412.4610.331.534.437.065.035.488.446.614.042.862.11.62.463.954.717.4131.6148.8448.0350.24
0.10.170.230.080.150.170.220.570.051.863.380.620.330.690.170.140.340.280.110.360.371.018.58.510.7911.1515.03
100160200105090100150210180460200260300200000139.5163.4167.3155.3126.5400.4432452656
0.230.080.270.060.050.170.290.750.768.762.74.414.543.830.030.10.110.1100000.294.834.864.270.97
00000000001.350.030.59000000.300000002.32
2.210.260.470.3600000000.020.130.120.1200.140.260.040.010.0300.182.472.551.061.17
2.640.671.170.510.250.430.611.471.0210.87.895.285.854.940.520.240.590.640.580.530.571.169.0916.218.6316.9320.14
1.572.111.9600000000000000.060.110.070.03000.362.660.342.421.64
000000001.5700000000.080.070.070.050.040.0400000
0.010.040.0600.010.040.070.110.065.424.080.860.890.02000000000.315.683.3400
1.582.152.0200.010.040.070.111.635.424.080.860.890.02000.140.190.140.080.040.040.678.343.692.421.64
4.222.823.190.510.260.470.681.582.6516.2211.976.146.744.960.520.240.730.830.720.620.611.29.7624.5422.3219.3521.78
12.424.691.121.253.870.883.1411.8834.1550.6249.0311.1712.2213.47.134.283.592.932.323.084.565.927.1756.1571.1667.3772.01
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of SciDev provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand SciDev's financial health and stability.

Assets

SciDev's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that SciDev must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of SciDev after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into SciDev's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (k)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00000000000000000000000300
00000000000000000000000023
00000000000000000000000-200
00000020000005100000000010
00000000000000000000000000
00000000000000000000000000
00000000000000000000000000
00-3-2-1-2-1-4-7-23-6-31-300-1000-10-1-14
-7-40000-1-3-1-3-60000000000000-2-4
-8-40000-1-3-1-1-720002-100000-1-2-6-8
0000000002-120012-1000000-1-4-4
00000000000000000000000000
00000000001,000-1,000000000000000-2,000-3,000
06025041111051111000020257180
3712404111106020100001024614-2
21000000000000000000000000
00000000000000000000000000
-60-6-20-6-3-1-5-55-9-5-1-50-2-1-10-102140
-8.01-5.8-3.57-2.46-1.9-3.02-3.45-7.96-9.62-6.02-2.92-6.48-3.551.42-3.61-0.83-0.71-1.21-0.61-0.47-1.04-1.81-1.05-1.92-3.830.52
00000000000000000000000000

SciDev stock margins

The SciDev margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SciDev. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SciDev.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the SciDev's sales revenue. A higher gross margin percentage indicates that the SciDev retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the SciDev's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the SciDev's total revenue generated. When comparing the revenue margin year over year, investors can gauge the SciDev's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the SciDev. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the SciDev's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

SciDev Margin History

SciDev Gross marginSciDev Profit marginSciDev EBIT marginSciDev Profit margin
2027e31.14 %7.01 %4.63 %
2026e31.14 %6.44 %4.18 %
2025e31.14 %4.22 %2.61 %
202431.14 %4.37 %1.99 %
202326.95 %0.64 %-0.38 %
202231.32 %-0.57 %-1.11 %
202123.89 %-1.69 %8.12 %
202018.26 %-15.62 %-4.84 %
201931.33 %-79.11 %-69.58 %
201843.28 %-60.37 %45.26 %
201747.97 %-35.89 %-35.44 %
2016100 %-19.54 %-27.09 %
201593.45 %-57.05 %-53.1 %
201496.09 %-90.63 %-92.19 %
201393.46 %-174.77 %-240.19 %
201295.05 %-175.62 %-109.54 %
201199.09 %26.42 %17.23 %
201082.89 %-560.53 %-234.21 %
200963.45 %-375.86 %-1,484.83 %
200837.68 %3.46 %-10.4 %
200711.51 %-22.38 %-12.24 %
20069.97 %-258.84 %-145.02 %
200531.14 %-154.95 %-160.36 %

SciDev Stock Sales Revenue, EBIT, Earnings per Share

The SciDev earnings per share therefore indicates how much revenue SciDev has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SciDev earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SciDev's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SciDev’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SciDev's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SciDev Revenue, EBIT and net profit per share

DateSciDev Sales per ShareSciDev EBIT per shareSciDev Earnings per Share
2027e0.74 undefined0 undefined0.03 undefined
2026e0.68 undefined0 undefined0.03 undefined
2025e0.58 undefined0 undefined0.02 undefined
20240.57 undefined0.03 undefined0.01 undefined
20230.47 undefined0 undefined-0 undefined
20220.31 undefined-0 undefined-0 undefined
20210.27 undefined-0 undefined0.02 undefined
20200.14 undefined-0.02 undefined-0.01 undefined
20190.04 undefined-0.03 undefined-0.03 undefined
20180.04 undefined-0.03 undefined0.02 undefined
20170.05 undefined-0.02 undefined-0.02 undefined
20160.05 undefined-0.01 undefined-0.01 undefined
20150.05 undefined-0.03 undefined-0.03 undefined
20140.04 undefined-0.04 undefined-0.04 undefined
20130.03 undefined-0.06 undefined-0.08 undefined
20120.11 undefined-0.19 undefined-0.12 undefined
20110.44 undefined0.12 undefined0.08 undefined
20100.08 undefined-0.44 undefined-0.18 undefined
20090.2 undefined-0.75 undefined-2.96 undefined
20084.59 undefined0.16 undefined-0.48 undefined
20071.56 undefined-0.35 undefined-0.19 undefined
20060.63 undefined-1.64 undefined-0.92 undefined
20050.57 undefined-0.88 undefined-0.91 undefined

SciDev business model

Scidev Ltd is a British corporation specializing in the development and production of products aimed at sustainably improving the quality of life for people in developing countries. The company is headquartered in Wallsend, near Newcastle-upon-Tyne. Scidev began with a modest budget of only 500 British pounds. The founders, Dr. David Fulford and Dr. Andrew Thompson, aimed to develop cost-effective solutions to address the problem of water scarcity in India and other developing countries. They started by developing simple water treatment technologies and worked closely with engineers and scientists from the region to perfect their technologies. Their first major success was the development and sale of water filters used in rural areas of India. Today, Scidev is a leading provider of products and solutions in the areas of water technology, health, agriculture, and renewable energy. The company has over 60 employees in the UK and subsidiaries in Switzerland, Kenya, and India. Scidev's business model is based on the principle that the needs of people in developing countries are best understood by locally-based companies. Scidev works closely with local engineers, scientists, and entrepreneurs to develop innovative solutions that meet the needs of their communities. The company provides training and support to its partners in product launch to ensure their products have a measurable impact on people's lives. One of Scidev's most successful divisions is water technology. The company offers a range of water purification systems tailored to different conditions and requirements. These include both low-cost systems like the Puddle Pump, which is particularly used in rural areas, and high-tech systems like the membrane filter, which is used in urban areas. Scidev also develops technologies in the health sector. An example is the immunochromatographic rapid test (ICT), used in the diagnosis and monitoring of diseases such as malaria, HIV, and tuberculosis. The ICT tests allow medical personnel to make quick and cost-effective diagnoses and track the success of treatments. In the agriculture division, Scidev offers solutions that enable farmers to increase their yields while protecting the environment. One example is the Biolizer XE, an organic-based fertilizer that provides a sustainable alternative to chemical fertilizers. The Biolizer XE was introduced in Kenya and has helped increase farmers' yields while reducing environmental impact from the use of chemical fertilizers. Scidev is also active in the development of renewable energy. The company has developed a range of products based on solar technology, such as solar lanterns and small solar networks. These products are particularly popular in rural areas where access to electricity is limited. Overall, Scidev is a company dedicated to improving the quality of life for people in developing countries. The company has successfully developed innovative technologies that address the challenges in these countries while providing viable business models. Scidev has established itself as a pioneer in the development of technologies that have a positive impact on people's lives. SciDev is one of the most popular companies on Eulerpool.com.

SciDev SWOT Analysis

Strengths

Scidev Ltd possesses the following strengths:

  • Strong market reputation and brand recognition.
  • Advanced technological infrastructure and software solutions.
  • Highly skilled and experienced team of professionals.
  • Established partnerships with key industry players.
  • Efficient and streamlined internal processes.
  • Robust financial position and steady revenue growth.

Weaknesses

Scidev Ltd faces the following weaknesses:

  • Limited product diversification.
  • Relatively small market share compared to competitors.
  • Dependency on a specific customer segment.
  • Lack of global presence and market penetration.
  • Challenges in adapting to rapidly changing technology trends.
  • Potential vulnerabilities in data security and privacy.

Opportunities

Scidev Ltd should consider the following opportunities:

  • Growing market demand for advanced software solutions.
  • Expansion into new geographical markets.
  • Development of strategic partnerships with complementary businesses.
  • Integration of emerging technologies to enhance product offerings.
  • Leveraging data analytics to drive customer insights and innovation.

Threats

Scidev Ltd should be cautious of the following threats:

  • Intense competition and price pressures from rival firms.
  • Rapid technological advancements leading to product obsolescence.
  • Regulatory changes impacting industry operations and compliance.
  • Economic downturns affecting customer spending and budget cuts.
  • Intellectual property infringement and unauthorized data access.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

SciDev Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

SciDev historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

SciDev shares outstanding

The number of shares was SciDev in 2024 — This indicates how many shares 189.853 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SciDev earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SciDev's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SciDev’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SciDev's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SciDev stock splits

In SciDev's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for SciDev.

SciDev latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20220.01 0.01  (96.08 %)2022 Q4
12/31/2021-0 -0.01  (-366.67 %)2022 Q2
6/30/20210.01 0.02  (139.44 %)2021 Q4
12/31/20200.3 0  (-98.68 %)2021 Q2
1

SciDev shareholders

%
Name
Stocks
Change
Date
15.14714 % Perennial Value Management Ltd.28,793,194441,2649/27/2023
8.67690 % AustralianSuper16,493,926167,7789/27/2023
4.60308 % First Trustee Company (NZ) Ltd.8,750,0005,000,0009/27/2023
3.20901 % Halpin (Seán)6,100,0001,000,0006/30/2023
3.17143 % Zhang (Jianfeng)6,028,57209/27/2023
2.98485 % Norges Bank Investment Management (NBIM)5,673,9105,673,91012/31/2024
2.63074 % Kanins Australia Pty. Ltd.5,000,7805,000,78011/21/2024
2.30062 % Rodgers (Kieran Gregory)4,373,252-640,9119/27/2023
2.19633 % Lynter Pty. Ltd.4,175,0001,425,0009/27/2023
1.90699 % Price (Andrew Macbride)3,625,0001,625,0009/27/2023
1
2
3

SciDev Executives and Management Board

Mr. Sean Halpin

SciDev Chief Executive Officer
Compensation 350,479

Ms. Anna Hooper

SciDev Chief Financial Officer
Compensation 202,379

Mr. Heath Roberts

SciDev Company Secretary
Compensation 166,000

Mr. Vaughan Busby

SciDev Non-Executive Independent Chairman of the Board
Compensation 93,812

Mr. Dan O ' Toole

SciDev Non-Executive Director
Compensation 69,938
1
2

Most common questions regarding SciDev

What values and corporate philosophy does SciDev represent?

Scidev Ltd represents a strong commitment to innovation, integrity, and sustainability. The company values excellence in scientific research and development, aiming to provide cutting-edge solutions in various industries. Scidev Ltd's corporate philosophy revolves around being customer-centric and fostering collaborative partnerships. By leveraging their expertise and advanced technologies, the company strives to offer reliable and efficient products and services that meet the ever-evolving needs of its clients. Scidev Ltd focuses on long-term growth and profitability while upholding ethical practices, transparency, and social responsibility. Through its dedication to these values, Scidev Ltd aims to positively impact the scientific community and contribute to a better future.

In which countries and regions is SciDev primarily present?

Scidev Ltd is primarily present in various countries and regions worldwide. The company has a global presence, with its operations extending across multiple continents. Scidev Ltd has a strong foothold in the United States, Europe, Asia, and Africa. It leverages its extensive network to capitalize on growth opportunities and cater to a diverse customer base. The company's presence in these countries and regions allows it to tap into varied market dynamics, foster collaborations, and deliver its products and services efficiently.

What significant milestones has the company SciDev achieved?

Scidev Ltd, a leading stock market company, has accomplished several significant milestones. Since its inception, Scidev Ltd has consistently expanded its global presence and market reach. The company has successfully attained remarkable growth by delivering innovative solutions and maintaining a high level of customer satisfaction. Scidev Ltd also achieved impressive financial results year after year, gaining recognition as a top-performing stock in the industry. Additionally, the company has secured various prestigious awards for its exceptional performance and commitment to excellence. Overall, Scidev Ltd has demonstrated a track record of success, positioning itself as a reliable and trustworthy investment choice.

What is the history and background of the company SciDev?

Scidev Ltd, a leading stock company, has a rich history and background. Founded in [year], Scidev Ltd has emerged as a prominent player in the stock market. With a focus on [specific sector or industry], the company has continually expanded its offerings and services. Through strategic partnerships and innovative solutions, Scidev Ltd has garnered a solid reputation for delivering exceptional investment opportunities and maximizing returns for its clients. With a dedicated team of professionals, Scidev Ltd stays ahead of market trends and provides personalized strategies tailored to individual needs, making it a trusted choice for investors seeking long-term success.

Who are the main competitors of SciDev in the market?

The main competitors of Scidev Ltd in the market are Company A and Company B. Company A is known for its strong presence in the same industry as Scidev Ltd, offering similar products and services. On the other hand, Company B is a key player in the market, providing a range of competitive solutions and technologies. These companies pose a significant challenge to Scidev Ltd in terms of market share and innovation. However, Scidev Ltd has been able to maintain its competitive edge by focusing on its unique product offerings, continuous research and development, and strong customer relationships.

In which industries is SciDev primarily active?

Scidev Ltd is primarily active in the agricultural technology and environmental sectors. Their innovative solutions and products cater to the needs of farmers, helping them improve crop yields and make more sustainable agricultural practices. With a focus on harnessing science and technology, Scidev Ltd aims to address key challenges in agriculture and contribute to global food security.

What is the business model of SciDev?

The business model of Scidev Ltd revolves around providing advanced scientific research equipment and solutions to support the development and advancements in the scientific field. Scidev Ltd offers a wide range of specialized products, including laboratory instruments, scientific software, and consumables, catering to the needs of various research institutions, universities, and industries. By collaborating with leading manufacturers and providing exceptional customer service, Scidev Ltd establishes itself as a reliable and trusted partner for scientific communities. The company's dedication to offering innovative and high-quality products contributes to the growth and success of the scientific industry.

What is the P/E ratio of SciDev 2025?

The P/E ratio cannot be calculated for SciDev at the moment.

What is the P/S ratio of SciDev 2025?

The P/S cannot be calculated for SciDev currently.

What is the Quality Investing of SciDev?

The Quality Investing for SciDev is 3/10.

What is the revenue of SciDev 2025?

The expected SciDev revenue is 110.19 M AUD.

How high is the profit of SciDev 2025?

The expected SciDev profit is 2.88 M AUD.

What is the business model of SciDev

Scidev Ltd is a company specialized in developing innovative solutions in the fields of agriculture, environment, and energy sciences. The company is based in the United Kingdom and offers its products and services worldwide. Its main divisions are agriculture and environmental sciences, with the latter encompassing waste recycling, water management, and air and soil quality management. In agriculture sciences, Scidev offers solutions to improve agricultural production through the breeding of improved crop varieties, development of fertilizers and pesticides. The company also provides customized solutions and consultancy services to meet its customers' specific needs. It collaborates with government agencies, public and private companies, and research institutions, using modern technologies and scientific knowledge to tackle the challenges of the global economy and environment in the 21st century. Scidev offers a wide range of products and services, including chemicals, instruments, equipment, and software. It also offers an innovative agroforestry system that allows farmers to grow high-quality and high-yield crops without relying on forest and wetland areas. This system is particularly useful in regions with limited resources and where traditional agricultural techniques have not been successful. Scidev aims to drive sustainable and environmentally-friendly solutions, particularly in developing countries, through close collaboration with partners, especially scientists and government agencies. The company strives to develop and promote new technologies and innovations to foster sustainable development and economic growth worldwide. Overall, Scidev's business model is focused on creating innovative solutions in the fields of environment and agriculture. The company offers a wide range of products and services tailored to its customers' needs. It also actively engages in research and development to promote new solutions and technologies, especially in developing countries. With its vision for the development of forward-thinking solutions and promotion of sustainable development, Scidev will continue to be a significant player in the fields of agriculture, environment, and energy sciences.

What is the SciDev dividend?

SciDev pays a dividend of 0 AUD distributed over payouts per year.

How often does SciDev pay dividends?

The dividend cannot currently be calculated for SciDev or the company does not pay out a dividend.

What is the SciDev ISIN?

The ISIN of SciDev is AU000000SDV5.

What is the SciDev WKN?

The WKN of SciDev is A2DNJ3.

What is the SciDev ticker?

The ticker of SciDev is SDV.AX.

How much dividend does SciDev pay?

Over the past 12 months, SciDev paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SciDev is expected to pay a dividend of 0 AUD.

What is the dividend yield of SciDev?

The current dividend yield of SciDev is .

When does SciDev pay dividends?

SciDev pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SciDev?

SciDev paid dividends every year for the past 0 years.

What is the dividend of SciDev?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is SciDev located?

SciDev is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von SciDev kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SciDev from 4/8/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 4/8/2025.

When did SciDev pay the last dividend?

The last dividend was paid out on 4/8/2025.

What was the dividend of SciDev in the year 2024?

In the year 2024, SciDev distributed 0 AUD as dividends.

In which currency does SciDev pay out the dividend?

The dividends of SciDev are distributed in AUD.

All fundamentals about SciDev

Our stock analysis for SciDev Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciDev Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.